Real-World Ritlecitinib Treatment of Severe Alopecia Areata in the United States: Patient Characteristics and Physician Satisfaction According to a Secondary Database Analysis.

Kurosky SK, Cha-Silva AS, Austin J, Mostaghimi A, Kindred C, Gauthier G, Sadrarhami M, Anderson P, Ungar B

Open source

DOI
10.1007/s13555-026-01773-3
Published
2026 Jul
Container
Dermatology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13555-026-01773-3,
  title = {Real-World Ritlecitinib Treatment of Severe Alopecia Areata in the United States: Patient Characteristics and Physician Satisfaction According to a Secondary Database Analysis.},
  author = {Kurosky SK and Cha-Silva AS and Austin J and Mostaghimi A and Kindred C and Gauthier G and Sadrarhami M and Anderson P and Ungar B},
  year = {2026},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-026-01773-3},
  url = {https://doi.org/10.1007/s13555-026-01773-3}
}

RIS

TY  - JOUR
TI  - Real-World Ritlecitinib Treatment of Severe Alopecia Areata in the United States: Patient Characteristics and Physician Satisfaction According to a Secondary Database Analysis.
AU  - Kurosky SK
AU  - Cha-Silva AS
AU  - Austin J
AU  - Mostaghimi A
AU  - Kindred C
AU  - Gauthier G
AU  - Sadrarhami M
AU  - Anderson P
AU  - Ungar B
PY  - 2026
JO  - Dermatology and therapy
DO  - 10.1007/s13555-026-01773-3
UR  - https://doi.org/10.1007/s13555-026-01773-3
ER  - 

APA

SK, K., AS, C., J, A., A, M., C, K., G, G., M, S., P, A., & B, U. (2026). Real-World Ritlecitinib Treatment of Severe Alopecia Areata in the United States: Patient Characteristics and Physician Satisfaction According to a Secondary Database Analysis.. Dermatology and therapy. https://doi.org/10.1007/s13555-026-01773-3

Source records